FIRST REPUBLIC ALERT: Bragar Eagel & Squire, P.C. is Investigating First Republic Bank on Behalf of First Republic Stockhold   •   Robooter to Showcases Multiple Products at Naidex Under the Theme of "Reboot Your Life"   •   Implementing United Nations Declaration on the Rights of Indigenous Peoples Act: Next phase of co-development   •   Parents' Top Choice: Stamford American's ELV recognized as best International Preschool   •   Leadership expert refreshes ancient archetypes in empowering book that transforms negative labels into leadership potential for   •   Tsinghua University Launches 'International Joint Mission on Climate Change and Carbon Neutrality' to Demonstrate Environmental   •   Nine-Time Billboard Charting Artist Kwanza Jones Releases 3 New Tracks To Go Face To Face Against Adversity   •   Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a   •   Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors   •   Organigram Announces Director Appointment   •   Greenberg Traurig's Nanette Aguirre Speaks at Hispanic Bar Association-NJ 2023 Women's Empowerment Leadership and Law Conference   •   Ampt and Innovenergy Expand Partnership in Europe   •   Maven Clinic Accelerates Growth in the United Kingdom with Acquisition of Naytal   •   Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp   •   Don't Forget to Enter The Eggland's Best "Recipe for a Healthy Family" Sweepstakes   •   New Data Demonstrates vMap’s Use Associated with Significantly Improved Outcomes in Atrial Fibrillation Treatment Study   •   NUCLIDIUM and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radio   •   HAT TRICK: KIA TELLURIDE, ALL-ELECTRIC EV6, K5, WIN "2023 BEST CARS FOR FAMILIES" AWARDS FROM U.S. NEWS & WORLD REPORT   •   Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer   •   Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore